Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Sep 7, 2008; 14(33): 5210-5216
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5210
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5210
Table 2 Combined chemotherapy-related toxicities to patients n (%)
| Toxicity | NCI-CTC grade | |||
| 1 | 2 | 3 | 4 | |
| Leukopenia | 9 (36.0) | 5 (20.0) | 2 (8.0) | 0 |
| Neutropenia | 6 (24.0) | 7 (28.0) | 2 (8.0) | 0 |
| Anemia | 2 (8.0) | 4 (16.0) | 0 | 0 |
| Thrombocytopenia | 7 (28.0) | 5 (20.0) | 6 (24.0) | 2 (8.0) |
| Diarrhea | 1 (4.0) | 0 | 0 | 0 |
| Nausea/emesis | 5 (20.0) | 0 | 0 | 0 |
| Peripheral neuropathy | 16 (64.0) | 0 | 0 | 0 |
| Pain | 2 (8.0) | 0 | 0 | 0 |
- Citation: Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP, Pan BR. Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. World J Gastroenterol 2008; 14(33): 5210-5216
- URL: https://www.wjgnet.com/1007-9327/full/v14/i33/5210.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.5210